Anticoagulation in type 2 myocardial infarctions: Lessons learned from the rivaroxaban in type 2 myocardial infarctions feasibility trial

BACKGROUND: Type 2 myocardial infarction (T2MI) occurs when myocardial oxygen demand exceeds myocardial oxygen supply. T2MIs occur more frequently and have worse outcomes compared to Type 1 myocardial infarction caused by an acute plaque rupture. No clinical trial evidence is available to guide phar...

Descripción completa

Detalles Bibliográficos
Autores principales: Gouda, Pishoy, Kay, Robert, Gupta, Arjun, Yuen, Tiffany, Elharram, Malik, Breau, Jean-Bernard, Gilani, Syed, Lau, Darren, Senaratne, Janek, Tsui, Albert KY., Tsuyuki, Ross, Graham, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173181/
https://www.ncbi.nlm.nih.gov/pubmed/37180843
http://dx.doi.org/10.1016/j.conctc.2023.101143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173181/
https://www.ncbi.nlm.nih.gov/pubmed/37180843
http://dx.doi.org/10.1016/j.conctc.2023.101143

Ejemplares similares